National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

[F-18]HX4
A 2-nitroimidazole labeled with the positron-emitting radioisotope fluorine F 18. HX4, the 2-nitroimidazole moiety of [F-18]HX4, is selectively bioreduced and bound in hypoxic tumor cells, permitting the imaging of hypoxic tumor cells with positron emission tomography (PET). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:851B gel, 852A, 99mTc-DTPA-mannosyl-dextran, [18F]-labeled substance P antagonist receptor quantifier, [18F]-ML-10
Next:abagovomab, abarelix, Abegrin, Abelcet, Aberel

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov